StockpollyBeta
Get App
Delisting riskPopularity #4,526
EVGN · NASDAQ · Biotechnology

Evogene (EVGN)

AI-guided small-molecule discovery for medicines and crop protection.

$0.4935
After hours+0.02 (+3.31%)
At close$0.4777(+3.17%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue414122210000
Cost of revenue100011200200
Gross profit304011110−200
788575543332
Research & development565333321221
223232211121
Selling & marketing1−2111−3100−100
General & administrative242135111210
Other expenses001000000000
Operating income−4−8−4−5−6−5−4−3−3−5−3−2
0000−151000−31
Interest income000025200011
Interest expense000030010040
Other non-operating income0000−2−1−2002−10
Income before tax−4−7−4−5−70−3−4−3−5−6−2
Income tax expense000000000000
Net income from continuing operations−4−7−4−5−70−3−4−3−5−6−2
Discontinued operations000−1−100−18000
Net income−4−7−4−5−80−3−44−5−6−2
EPS, basic−$0.81−$1.30−$0.76−$1.06−$1.31$0.06−$0.38−$0.62$0.44−$0.61−$0.60−$0.14
EPS, diluted−$0.81−$1.30−$0.76−$1.06−$1.31$0.06−$0.38−$0.62$0.44−$0.61−$0.60−$0.14
Weighted average shares, basic55556777991012
Weighted average shares, diluted55556777991012
EBITDA−3−7−3−4−4−3−2−3−2−6−2−2
Depreciation & amortization111001100000
EBIT−4−8−4−4−4−3−3−3−2−7−2−2